News overview

The dialysis users are the ultimate experts

Direct involvement of dialysis users is essential for the succes of this project and crucial for the development of the WEAKID device! Therefore we appreciate that already 65 surveys have been completed and we expect to reach our goal of 100 this summer. We will also soon plan the interactive focus groups: the first one will take place in the Netherlands, with similar sessions later in Spain and Italy.

The FIH trial continues in Madrid with the 6th participant

In February 2025, the 6th participant in the First-in-Human trial will be included at the Hospital Universitario la Paz, in Madrid.

The FIH trial continues in Modena with the 5th participant

In September 2024, the 5th participant in the First-in-Human trial will be included at the University Hospital of Modena.

Approval to start FIH trial in Modena and Madrid

The sites in Modena (Italy) and Madrid (Spain) have received approval to execute the First-in-Human CORDIAL trial.

The CORDIAL survey for patients to investigate the preferences for new peritoneal dialysis devices is now available in English, Dutch, Spanish and Italian.

CORDIAL survey available in English and Dutch

The CORDIAL survey for patients to investigate the preferences for new peritoneal dialysis devices is now available in English and Dutch.

June newsletter

Our new newsletter is available!

The project CORDIAL has been extended from 3 years to 3.5 years. The current new end date is 31 December 2024. A second extension will be evaluated after summer 2024.

In May 2024, the fourth patient completed the first-in-human trial in the Netherlands. After summer we will continue the trial in Spain and Italy.

Nanodialysis at home dialysis congress Cologne

Nanodialysis presented the CORDIAL device at the home dialysis congress was held in Cologne (Germany), which was held o the 26th and 27th of April, 2024.